{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:37:46Z","timestamp":1773682666403,"version":"3.50.1"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T00:00:00Z","timestamp":1332979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0032769","type":"journal-article","created":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T21:20:37Z","timestamp":1333056037000},"page":"e32769","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Priming with a Recombinant Pantothenate Auxotroph of Mycobacterium bovis BCG and Boosting with MVA Elicits HIV-1 Gag Specific CD8+ T Cells"],"prefix":"10.1371","volume":"7","author":[{"given":"Rosamund","family":"Chapman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enid","family":"Shephard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Stutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Douglass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasan","family":"Sambandamurthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Ryffel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Lise","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,3,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1128\/JVI.02689-06","article-title":"Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8(+) T-cell epitopes.","volume":"81","author":"I Honeyborne","year":"2007","journal-title":"Journal of Virology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8(+) T-cell responses to different HIV proteins have discordant associations with viral load.","volume":"13","author":"P Kiepiela","year":"2007","journal-title":"Nature Medicine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1172\/JCI0215985","article-title":"Strategies for an HIV vaccine.","volume":"110","author":"NL Letvin","year":"2002","journal-title":"J Clin Invest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"10288","DOI":"10.1128\/JVI.01681-06","article-title":"Priming-boosting vaccination with recombinant <italic>Mycobacterium bovis<\/italic> bacillus Calmette-Guerin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity (vol 79, pg 12871, 2005).","volume":"80","author":"Y Ami","year":"2006","journal-title":"Journal of Virology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1128\/JVI.02544-08","article-title":"Recombinant <italic>Mycobacterium bovis<\/italic> BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional simian immunodeficiency virus-specific T-cell responses.","volume":"83","author":"MJ Cayabyab","year":"2009","journal-title":"J Virol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1016\/j.vaccine.2009.05.064","article-title":"A prime-boost immunisation regimen using recombinant BCG and Pr55(gag) virus-like particle vaccines based on HIV type 1 subtype C successfully elicits Gag-specific responses in baboons.","volume":"27","author":"GK Chege","year":"2009","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/08830189009061766","article-title":"Development of a BCG recombinant vehicle for candidate AIDS vaccines.","volume":"7","author":"A Aldovini","year":"1990","journal-title":"Int Rev Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/351456a0","article-title":"New use of BCG for recombinant vaccines.","volume":"351","author":"CK Stover","year":"1991","journal-title":"Nature"},{"key":"ref9","first-page":"229","article-title":"Efficacy and safety of live recombinant BCG vaccines.","volume":"84","author":"MS Hanson","year":"1995","journal-title":"Dev Biol Stand"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1016\/j.vaccine.2007.01.087","article-title":"Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine.","volume":"25","author":"M Dennehy","year":"2007","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/infdis\/172.3.698","article-title":"Recombinant bacille Calmette-Guerin priming against measles.","volume":"172","author":"GJ Fennelly","year":"1995","journal-title":"J Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.virusres.2007.03.016","article-title":"Rabbits immunised with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L2E7E2 genes induces regression of established papillomas.","volume":"127","author":"VA Govan","year":"2007","journal-title":"Virus Research"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin.","volume":"115","author":"L Grode","year":"2005","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/372552a0","article-title":"Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi.","volume":"372","author":"S Langermann","year":"1994","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1084\/jem.178.1.197","article-title":"Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.","volume":"178","author":"CK Stover","year":"1993","journal-title":"J Exp Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1128\/JVI.80.4.1645-1652.2006","article-title":"Generation of CD8+ T-cell responses by a recombinant nonpathogenic <italic>Mycobacterium smegmatis<\/italic> vaccine vector expressing human immunodeficiency virus type 1 Env.","volume":"80","author":"MJ Cayabyab","year":"2006","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1002\/eji.201141962","article-title":"Optimizing HIV-1-specific CD8(+) T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors.","volume":"41","author":"R Hopkins","year":"2011","journal-title":"Eur J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e20067","DOI":"10.1371\/journal.pone.0020067","article-title":"Dual neonate vaccine platform against HIV-1 and M. tuberculosis.","volume":"6","author":"R Hopkins","year":"2011","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"9408","DOI":"10.1128\/JVI.00707-07","article-title":"Vaccine platform for prevention of tuberculosis and mother-to-child transmission of human immunodeficiency virus type 1 through breastfeeding.","volume":"81","author":"EJ Im","year":"2007","journal-title":"J Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.1128\/JVI.00726-10","article-title":"Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques.","volume":"84","author":"M Rosario","year":"2010","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"516219","DOI":"10.1155\/2011\/516219","article-title":"Newborn mice vaccination with BCG.HIVA(2)(2)(2)+MVA.HIVA enhances HIV-1-specific immune responses: influence of age and immunization routes.","volume":"2011","author":"N Saubi","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.4049\/jimmunol.176.3.1784","article-title":"Induction of positive cellular and humoral immune responses by a prime-boost vaccine encoded with simian immunodeficiency virus gag\/pol.","volume":"176","author":"K Someya","year":"2006","journal-title":"J Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1128\/CVI.00407-06","article-title":"Recombinant Mycobacterium bovis Bacillus Calmette-Gue&apos;rin elicits human immunodeficiency virus type 1 envelope-specific T lymphocytes at mucosal sites.","volume":"14","author":"JS Yu","year":"2007","journal-title":"Clinical and Vaccine Immunology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1128\/JVI.02607-09","article-title":"Novel recombinant Mycobacterium bovis BCG, ovine atadenovirus, and modified vaccinia virus Ankara vaccines combine to induce robust human immunodeficiency virus-specific CD4 and CD8 T-cell responses in rhesus macaques.","volume":"84","author":"M Rosario","year":"2010","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1128\/CVI.00407-06","article-title":"Recombinant Mycobacterium bovis Bacillus Calmette-Gue&apos;rin elicits human immunodeficiency virus type 1 envelope-specific T lymphocytes at mucosal sites.","volume":"14","author":"JS Yu","year":"2007","journal-title":"Clinical and Vaccine Immunology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1021\/jm701372r","article-title":"5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxam ide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs.","volume":"51","author":"S Velaparthi","year":"2008","journal-title":"J Med Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1016\/j.vaccine.2006.05.097","article-title":"Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis.","volume":"24","author":"VK Sambandamurthy","year":"2006","journal-title":"Vaccine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1128\/IAI.00434-08","article-title":"A replication-limited recombinant <italic>Mycobacterium bovis<\/italic> BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG.","volume":"76","author":"MV Tullius","year":"2008","journal-title":"Infect Immun"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1086\/378298","article-title":"Danish bacille Calmette-Guerin vaccine-induced disease in human immunodeficiency virus-infected children.","volume":"37","author":"AC Hesseling","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1016\/j.vaccine.2007.06.045","article-title":"BCG and HIV reconsidered: moving the research agenda forward.","volume":"25","author":"AC Hesseling","year":"2007","journal-title":"Vaccine"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e15857","DOI":"10.1371\/journal.pone.0015857","article-title":"Lysine auxotrophy combined with deletion of the SecA2 gene results in a safe and highly immunogenic candidate live attenuated vaccine for tuberculosis.","volume":"6","author":"J Hinchey","year":"2011","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.68.5.2888-2898.2000","article-title":"Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis.","volume":"68","author":"MK Hondalus","year":"2000","journal-title":"Infect Immun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/nm765","article-title":"A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis.","volume":"8","author":"VK Sambandamurthy","year":"2002","journal-title":"Nat Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/IAI.72.5.3031-3037.2004","article-title":"Protection elicited by a double leucine and pantothenate auxotroph of Mycobacterium tuberculosis in guinea pigs.","volume":"72","author":"SL Sampson","year":"2004","journal-title":"Infection and Immunity"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1016\/j.vaccine.2009.05.048","article-title":"Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.","volume":"27","author":"R Sun","year":"2009","journal-title":"Vaccine"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.vaccine.2009.09.087","article-title":"Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8(+) T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice.","volume":"28","author":"UDK Ranganathan","year":"2009","journal-title":"Vaccine"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1054\/tube.2002.0374","article-title":"Expression of foreign genes in <italic>Mycobacterium bovis<\/italic> BCG strains using different promoters reveals instability of the <italic>hsp60<\/italic> promoter for expression of foreign genes in <italic>Mycobacterium bovis<\/italic> BCG strains.","volume":"82","author":"M Al Zarouni","year":"2002","journal-title":"Tuberculosis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0923-2508(94)90040-X","article-title":"Structural instability of recombinant plasmids in mycobacteria.","volume":"145","author":"F Haeseleer","year":"1994","journal-title":"Res Microbiol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0264-410X(98)80121-7","article-title":"Genetic rearrangements leading to disruption of heterologous gene expression in mycobacteria: an observation with <italic>Escherichia coli<\/italic> beta-galactosidase in <italic>Mycobacterium smegmatis<\/italic> and its implication in vaccine development.","volume":"16","author":"D Kumar","year":"1998","journal-title":"Vaccine"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.4049\/jimmunol.173.7.4607","article-title":"Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa.","volume":"173","author":"AM Masemola","year":"2004","journal-title":"J Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2174\/157016210791208686","article-title":"Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.","volume":"8","author":"R Chapman","year":"2010","journal-title":"Curr HIV Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/clinids\/20.4.1001","article-title":"Bacterial vaccine vectors and bacillus Calmette-Guerin.","volume":"20","author":"JD Cirillo","year":"1995","journal-title":"Clin Infect Dis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1586\/14760584.5.6.827","article-title":"Progress towards an HIV vaccine based on recombinant bacillus Calmette-Guerin: failures and challenges.","volume":"5","author":"J Joseph","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.4049\/jimmunol.146.12.4301","article-title":"Antiviral protection by CD8+ versus CD4+ T cells. CD8+ T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent IL.","volume":"146","author":"D Binder","year":"1991","journal-title":"J Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.4049\/jimmunol.168.11.5737","article-title":"Multiple mechanisms compensate to enhance tumor-protective CD8(+) T cell response in the long-term despite poor CD8(+) T cell priming initially: comparison between an acute versus a chronic intracellular bacterium expressing a model antigen.","volume":"168","author":"R Dudani","year":"2002","journal-title":"J Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.4049\/jimmunol.172.6.3491","article-title":"Prolonged antigen presentation, APC\u2212, and CD8+ T cell turnover during mycobacterial infection: comparison with Listeria monocytogenes.","volume":"172","author":"H van Faassen","year":"2004","journal-title":"J Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.4049\/jimmunol.174.9.5341","article-title":"Reducing the stimulation of CD8+ T cells during infection with intracellular bacteria promotes differentiation primarily into a central (CD62LhighCD44high) subset.","volume":"174","author":"H van Faassen","year":"2005","journal-title":"J Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20070784","article-title":"Superior control of HIV-1 replication by CD8(+) T cells is reflected by their avidity, polyfunctionality, and clonal turnover.","volume":"204","author":"JR Almeida","year":"2007","journal-title":"Journal of Experimental Medicine"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev.med.60.041807.123549","article-title":"Emerging concepts in the immunopathogenesis of AIDS.","volume":"60","author":"DC Douek","year":"2009","journal-title":"Annu Rev Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1128\/JVI.01707-10","article-title":"Epitope mapping of HIV-specific CD8+ T cell responses by multiple immunological readouts reveals distinct specificities defined by function.","volume":"85","author":"M Richmond","year":"2011","journal-title":"J Virol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1128\/CVI.00407-06","article-title":"Recombinant Mycobacterium bovis Bacillus Calmette-Gue&apos;rin elicits human immunodeficiency virus type 1 envelope-specific T lymphocytes at mucosal sites.","volume":"14","author":"JS Yu","year":"2007","journal-title":"Clinical and Vaccine Immunology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1082305","article-title":"Requirement for CD4 T cell help in generating functional CD8 T cell memory.","volume":"300","author":"DJ Shedlock","year":"2003","journal-title":"Science"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.1083317","article-title":"Defective CD8 T cell memory following acute infection without CD4 T cell help.","volume":"300","author":"JC Sun","year":"2003","journal-title":"Science"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"8330","DOI":"10.1073\/pnas.102055799","article-title":"Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH.","volume":"99","author":"D Kaushal","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1073\/pnas.052705399","article-title":"Mycobacterium tuberculosis WhiB3 interacts with RpoV to affect host survival but is dispensable for in vivo growth.","volume":"99","author":"AJ Steyn","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/088922203762688649","article-title":"Characterization and selection of HIV-1 subtype C isolates for use in vaccine development.","volume":"19","author":"C Williamson","year":"2003","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref57","first-page":"129","article-title":"Electroporation of mycobacteria.","author":"T Parish","year":"1998"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0264-410X(96)00072-2","article-title":"Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model.","volume":"14","author":"LS Wyatt","year":"1996","journal-title":"Vaccine"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.4049\/jimmunol.161.6.2985","article-title":"The MHC class I-restricted immune response to HIV-gag in BALB\/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D.","volume":"161","author":"M Mata","year":"1998","journal-title":"J Immunol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.4049\/jimmunol.163.3.1449","article-title":"Th1 T cell responses to HIV-1 Gag protein delivered by a Listeria monocytogenes vaccine are similar to those induced by endogenous listerial antigens.","volume":"163","author":"M Mata","year":"1999","journal-title":"J Immunol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1016\/S0264-410X(03)00406-7","article-title":"Construction and characterisation of a candidate HIV-1 subtype C DNA vaccine for South Africa.","volume":"21","author":"JH van Harmelen","year":"2003","journal-title":"Vaccine"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0032769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T11:02:16Z","timestamp":1713783736000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0032769"}},"subtitle":[],"editor":[{"given":"T. Mark","family":"Doherty","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,29]]},"references-count":61,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0032769","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,29]]}}}